Dermatology Doctors in Auburn, MA Accepting Medicare

3 Dermatology doctors found. Showing 1 - 3

John R Person, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 385 Southbridge St, Auburn, MA 01501 Phone: 508-721-1180    Fax: 508-721-9106

Dr. Daniel Evan Viders, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 207 Southbridge St, Auburn, MA 01501 Phone: 508-832-7118    Fax: 508-832-4758

Casey Brown, PA-C Dermatology Medicare: Accepting Medicare Assignments Practice Location: 207 Southbridge St, Auburn, MA 01501 Phone: 508-832-7118    Fax: 508-832-7166

News Archive

Payers, benefits administrators look for ways to reduce costs of managing benefits programs

Sending communications on healthcare benefits through the mail is an important channel in engaging members as they make benefits decisions and as program managers seek to influence member behavior, according to a study on Healthcare Benefit Communications Preferences by Pitney Bowes Management Services, Inc., a wholly owned subsidiary of Pitney Bowes Inc.

SAGE to launch European Edition of 'Foot & Ankle Specialist'

SAGE is to launch Foot & Ankle Specialist - European Edition from February 2011. The journal will be an international edition of Foot & Ankle Specialist (FAS), a bimonthly controlled circulation journal launched in 2008 publishing peer-reviewed clinical information for foot and ankle caregivers.

FDA accepts Navidea's resubmitted NDA for Lymphoseek

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced today that the U.S. Food and Drug Administration (FDA) has accepted the filing of the Company's October 30, 2012 resubmission of its New Drug Application (NDA) for Lymphoseek (Technetium Tc 99m Tilmanocept) Injection.

Lighthouse Guild doctor offers tips to help visually impaired people walk the Monday Mile

Nearly 14 million Americans - about one out of every 20 people - have low vision, according to The Centers for Disease Control and Prevention. Eye-care professionals use the term "low vision" to describe significant visual impairment that cannot be corrected with standard glasses, contact lenses, medicine or eye surgery.

Weight loss pill Qnexa wins panel vote and awaits approval

The drug was rejected in a 10-6 vote the first time it came before a Food and Drug Administration (FDA) advisory panel, in 2010, due to safety concerns. However when the medication returned for another review in February, the advisory committee gave it near-unanimous approval (20-2). Because the FDA often follows the advisory panel's advice, Qnexa is likely to get FDA approval, probably by mid-April.

Read more Medical News

› Verified 5 days ago